The presence of H ürthle cells does not increase the risk of malignancy in most Bethesda categories in thyroid fine-needle aspirates.

CONCLUSION: Although Hürthle cells have been considered by clinicians as an "atypical cell" their presence does not increase the risk of malignancy within BSRTC categories overall. However, when predominant Hürthle cell change is present, the risk of malignancy is increased in the benign cytology/BSRTC category II. PMID: 32013786 [PubMed - as supplied by publisher]
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research